Duloxetine
- Product NDC
- 70518-2855
- 11-digit product format
- 705182855
- Labeler code
- 70518
- Product ID
- 70518-2855_dcef77c0-1b29-ce41-e053-2a95a90aff8c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Duloxetine
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA203197
- Marketing category
- ANDA
- Marketing start
- 2020-08-24
- Marketing end
- 0000-00-00
- Substance
- DULOXETINE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2855-0 | 70518285500 | 30 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (70518-2855-0) | 2020-08-24 | 0000-00-00 | No | No | Current |
| 70518-2855-1 | 70518285501 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70518-2855-1) | 2021-02-03 | 0000-00-00 | No | No | Current |
| 70518-2855-2 | 70518285502 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70518-2855-2) | 2021-02-26 | 0000-00-00 | No | No | Current |